IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.
IFN-gamma regulates the immunogenicity of target cells by increasing their expression of HLA class I molecules. This facilitates the T cell receptor-mediated recognition by CD8(+) T cells but decreases target cell sensitivity to lysis by NK cells due to engagement of inhibitory NK receptors. In this...
Main Authors: | Malmberg, K, Levitsky, V, Norell, H, de Matos, C, Carlsten, M, Schedvins, K, Rabbani, H, Moretta, A, Söderström, K, Levitskaya, J, Kiessling, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2002
|
Similar Items
-
A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
by: Michaëlsson, J, et al.
Published: (2002) -
Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.
by: de Matos, C, et al.
Published: (2007) -
CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
by: Söderström, K, et al.
Published: (1997) -
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
by: Braud, V, et al.
Published: (1998) -
Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
by: Nielsen, N, et al.
Published: (2014)